Characteristics of adult intestinal failure centers: An international multicenter survey.


Journal

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition
ISSN: 1941-2452
Titre abrégé: Nutr Clin Pract
Pays: United States
ID NLM: 8606733

Informations de publication

Date de publication:
Jun 2023
Historique:
revised: 13 09 2022
received: 20 06 2022
accepted: 02 10 2022
medline: 8 5 2023
pubmed: 30 10 2022
entrez: 29 10 2022
Statut: ppublish

Résumé

Current guidelines recommend that patients with chronic intestinal failure (CIF) should be managed by a multidisciplinary team (MDT). However, the characteristics of real-world IF centers and the patients they care for are lacking. The study aims to describe IF center characteristics as well as characteristics of patients with CIF across different global regions. This is an international multicenter study of adult IF centers using a survey. The questionnaire survey included questions regarding program and patient characteristics. Thirty-three investigational centers were invited to participate. Each center was asked to answer the survey questions as one MDT. The survey center response rate was 91%. The median number of patients with CIF per center was 128 (range, 30-380). The most common disciplines reported were gastroenterologist (93%), dietitian (90%), nurse (83%), and advanced practitioner (nurse practitioner and physician assistant, 77%). There were centers that did not have a pharmacist, surgeon, psychologist, and social worker (30%, 37%, 60%, and 70%, respectively). The median full-time equivalents (FTEs) per 100 patients were 1.1 for nurses, 1 for dietitians, 1 for advanced practitioners, and 0.9 for gastroenterologists. Short bowel syndrome was the most common cause of CIF (50%) followed by intestinal dysmotility (20%). The majority of centers were managing around 100 patients with CIF. Despite the widespread use of the MDT, there are some variances in team characteristics. Gastroenterologists were the most common physicians supporting MDTs. In IF centers, one FTE of each core discipline was supported to manage 100 patients with CIF.

Sections du résumé

BACKGROUND BACKGROUND
Current guidelines recommend that patients with chronic intestinal failure (CIF) should be managed by a multidisciplinary team (MDT). However, the characteristics of real-world IF centers and the patients they care for are lacking. The study aims to describe IF center characteristics as well as characteristics of patients with CIF across different global regions.
METHODS METHODS
This is an international multicenter study of adult IF centers using a survey. The questionnaire survey included questions regarding program and patient characteristics. Thirty-three investigational centers were invited to participate. Each center was asked to answer the survey questions as one MDT.
RESULTS RESULTS
The survey center response rate was 91%. The median number of patients with CIF per center was 128 (range, 30-380). The most common disciplines reported were gastroenterologist (93%), dietitian (90%), nurse (83%), and advanced practitioner (nurse practitioner and physician assistant, 77%). There were centers that did not have a pharmacist, surgeon, psychologist, and social worker (30%, 37%, 60%, and 70%, respectively). The median full-time equivalents (FTEs) per 100 patients were 1.1 for nurses, 1 for dietitians, 1 for advanced practitioners, and 0.9 for gastroenterologists. Short bowel syndrome was the most common cause of CIF (50%) followed by intestinal dysmotility (20%).
CONCLUSION CONCLUSIONS
The majority of centers were managing around 100 patients with CIF. Despite the widespread use of the MDT, there are some variances in team characteristics. Gastroenterologists were the most common physicians supporting MDTs. In IF centers, one FTE of each core discipline was supported to manage 100 patients with CIF.

Identifiants

pubmed: 36309481
doi: 10.1002/ncp.10926
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

657-663

Informations de copyright

© 2022 The Authors. Nutrition in Clinical Practice published by Wiley Periodicals LLC on behalf of American Society for Parenteral and Enteral Nutrition.

Références

Pironi L, Arends J, Baxter J, et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr. 2015;34(2):171-180.
Allan P, Lal S. Intestinal failure: a review. F1000Res. 2018;7:85.
Pironi L, Arends J, Bozzetti F, et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35(2):247-307.
Pironi L, Goulet O, Buchman A, et al. Outcome on home parenteral nutrition for benign intestinal failure: a review of the literature and benchmarking with the European prospective survey of ESPEN. Clin Nutr. 2012;31(6):831-845.
Baxter JP, Fayers PM, McKinlay AW. A review of the quality of life of adult patients treated with long-term parenteral nutrition. Clin Nutr. 2006;25(4):543-553.
Canovai E, Ceulemans LJ, Peers G, et al. Cost analysis of chronic intestinal failure. Clin Nutr. 2019;38(4):1729-1736.
Pironi L, Steiger E, Brandt C, et al. Home parenteral nutrition provision modalities for chronic intestinal failure in adult patients: an international survey. Clin Nutr. 2020;39(2):585-591.
Cuerda C, Pironi L, Arends J, et al. ESPEN practical guideline: clinical nutrition in chronic intestinal failure. Clin Nutr. 2021;40(9):5196-5220.
Pohju AK, Pakarinen MP, Sipponen TM. Intestinal failure in Finland: prevalence and characteristics of an adult patient population. Eur J Gastroenterol Hepatol. 2021;33(12):1505-1510.
Pironi L, Steiger E, Joly F, et al. Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN; European Society for Clinical Nutrition and Metabolism. Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: an international multicenter survey. Clin Nutr ESPEN. 2021;45:433-441.
Efficacy and Safety Evaluation of glepaglutide in treatment of SBS (EASE SBS 1). ClinicalTrials.gov identifier: NCT03690206. Updated April 8, 2022. Accessed May 19, 2022. https://www.clinicaltrials.gov/ct2/show/NCT03690206
Lakananurak N, Gramlich L. Exploring gaps and opportunities in the management of short bowel syndrome intestinal failure patients. Clin Nutr ESPEN. 2020;40:P517.
Bakker H, Bozzetti F, Staun M, et al. Home parenteral nutrition in adults: a european multicentre survey in 1997. ESPEN-Home Artificial Nutrition Working Group. Clin Nutr. 1999;18(3):135-140.
van Gossum A, Bakker H, de Francesco A, et al. Home parenteral nutrition in adults: a multicentre survey in Europe in 1993. Clin Nutr. 1996;15(2):53-59.
Baxter JP, Gillanders L, Angstmann K, et al. Home parenteral nutrition: an international benchmarking exercise. e-SPEN J. 2012;7(5):e211-e214.
Spolidoro JVN, Souza MC, Goldani HAS, et al. International Latin American survey on pediatric intestinal failure team. Nutrients. 2021;13(8):2754.
Neelis E, de Koning B, van Winckel M, Tabbers M, Hill S, Hulst J. Wide variation in organisation and clinical practice of paediatric intestinal failure teams: an international survey. Clin Nutr. 2018;37(6 pt A):2271-2279.

Auteurs

Narisorn Lakananurak (N)

Division of Clinical Nutrition, Department of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand.
Department of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Lisa Moccia (L)

Cleveland Clinic, Cleveland, Ohio, USA.

Elizabeth Wall (E)

Department of Clinical Nutrition, University of Chicago Medicine, Chicago, Illinois, USA.

Jean Herlitz (J)

Department of Clinical Nutrition, University of Chicago Medicine, Chicago, Illinois, USA.

Hilary Catron (H)

University of Nebraska Medical Center, Omaha, Nebraska, USA.

Edward Lozano (E)

Department of Clinical Pharmacy, University of Chicago Medicine, Chicago, Illinois, USA.

Adela Delgado (A)

Alberta Health Services, Royal Alexandra Hospital, Edmonton, Alberta, Canada.

Tim Vanuytsel (T)

Department of Gastroenterology and Hepatology, Katholieke Universiteit Leuven, Leuven, Belgium.

David Mercer (D)

University of Nebraska Medical Center, Omaha, Nebraska, USA.

Sophie Pevny (S)

Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Division of Hepatology and Gastroenterology, Medical Department, Berlin Institute of Health, Berlin, Germany.

Mark Berner-Hansen (M)

Zealand Pharma, Copenhagen, Denmark.
Digestive Disease Center, Bispebjerg University Hospital of Copenhagen, Copenhagen, Denmark.

Leah Gramlich (L)

Department of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH